On Feb. 22, 2022, Washington University in St. Louis announced that a blood test developed at the University’s School of Medicine had proven highly accurate in detecting early signs of Alzheimer’s disease in a study involving nearly 500 patients from across three continents, providing further evidence that the test should be considered for routine screening and diagnosis. The study was published in the journal Neurology.